Locked content Portuguese watchdog approves Stemlab acquisition

The Portuguese Office of Competition Protection (Autoridade da Concorrencia) gave consent to the acquisition of Stemlab by Polski Bank Komórek Macierzystych (PBKM), PBKM said on Friday. In mid-July, PBKM announced the acquisition of majority stake in the Portuguese Stemlab for €16.5 million (around ...

Locked content PBKM Q1 net profit grows to PLN 10 mln

Polish stem cell bank PBKM recorded Q1 net profit of PLN 9.96 million compared to PLN 5.89 million a year ago, the company said. Operating profit amounted to PLN 11.63 million compared to PLN 8.32 million profit in Q1 2017.  EBITDA  was  PLN 13.06 million, up 38.1 percent compared to a year earlier....

Locked content PBKM subsidiary buys Biocell Lugano

Famicord, a subsidiary of Polish stem cell bank PBKM, acquired 100 percent of shares in Biocell Lugano, PBKM said in a statement. The maximum price is set at €1.6 million (PLN 6.9 million). Under the agreement, the payment will be executed in three tranches of PLN 0.25 million, PLN 0.75 million and ...

Locked content Stem Cell Bank to offer 1.2 mln shares

Polish stem cell bank PBKM will offer 1.2 million shares valued at PLN 47 per share in its upcoming IPO, the company said in a statement. As many as 1.06 mln share will go to institutional investors. An offer is planned for the first half of 2016, but the final decision on the date will depend…...

Locked content KNF approves Polish Stem Cell Bank prospectus

Poland’s financial watchdog (KNF) has approved the prospectus from the Polish Stem Cell Bank (Polski Bank Komórek Macierzystych) to issue A, B, C, D, E, F, G, H, I, J series shares. The investment companies are mBank Brokerage House and Haitong Bank. An offer is planned for the first half of 2...